Secondary Hyperparathyroidism
123
4
5
92
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
43 trials with published results (35%)
Research Maturity
92 completed trials (75% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
8.9%
11 terminated out of 123 trials
89.3%
+2.8% vs benchmark
46%
57 trials in Phase 3/4
47%
43 of 92 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 92 completed trials
Clinical Trials (123)
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participants
A Mass Balance Study of [14C] SHR6508 in Chinese Hemodialysis Subjects With Secondary Hyperparathyroidism
A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
The Trial of SHR6508 in Secondary Hyperparathyroidism
Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2
Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-1
Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism
Precision Medicine Approaches to Renal Osteodystrophy
Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients
LEO 27847 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Secondary Hyperparathyroidism Patients
Single-Cell Sequence Technology Used to Reveal Heterogeneity of Secondary Hyperparathyroidism
A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.
A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis
Intraoperative Parathyroid Hormone Monitoring to Guide Surgery in Renal hyperparathyroIdism
The Effect of Increasing Dialysate Calcium on T50 in Subjects With Secondary Hyperparathyroidism and ESKD
Quality of Life Change in Patients Undergoing Parathyroidectomy With End-stage Renal Failure
Impact of Parathyroidectomy on Cardiovascular Calcification in Dialysis-dependent Patients
Changes in Cardiac Functions in Patients Treated With Parathyroidectomy for Secondary Hyperparathyroidism
Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol